Ahmed Anwar, Das Manoj K, Dev Vas, Saifi Muheet A, Sharma Yagya D
Department of Biotechnology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India.
Antimicrob Agents Chemother. 2006 Apr;50(4):1546-9. doi: 10.1128/AAC.50.4.1546-1549.2006.
Quadruple mutations in the Plasmodium falciparum dihydrofolate reductase (PFDHFR) enzyme give rise to the highest level of pyrimethamine resistance leading to treatment failures. We describe here the presence of these quadruple mutations in a majority of P. falciparum isolates from Car Nicobar (Andaman and Nicobar) Island, India. Isolates from the mainland, however, continue to show a prevalence of double PFDHFR mutations and some with triple but none with quadruple mutations. In conclusion, the antifolate drug pressure is very high in the island, which should be a cause of concern for the malaria control program in the country.
恶性疟原虫二氢叶酸还原酶(PFDHFR)中的四重突变导致了最高水平的乙胺嘧啶耐药性,进而引发治疗失败。我们在此描述了来自印度卡尔尼科巴岛(安达曼和尼科巴群岛)的大多数恶性疟原虫分离株中存在这些四重突变。然而,来自印度大陆的分离株仍显示出双PFDHFR突变的流行情况,一些存在三重突变,但没有四重突变。总之,该岛屿的抗叶酸药物压力非常高,这应该引起该国疟疾控制项目的关注。